Cancer of the Head and Neck
31
2
3
19
Key Insights
Highlights
Success Rate
86% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.7%
3 terminated out of 31 trials
86.4%
-0.1% vs benchmark
13%
4 trials in Phase 3/4
32%
6 of 19 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 19 completed trials
Clinical Trials (31)
Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma
Phase Ib Trial of Multivalent Autophagosome Vaccine With or Without GITR Agonist, With Anti-PD-1 Immunotherapy in HNSCC
Real-time Activity Monitoring to Prevent Admissions During RadioTherapy
Adjuvant Radiotherapy in Early Stage Oral Cancers
Pyrimethamine as an Inhibitor of NRF2 in HPV-unrelated Locally Advanced Head and Neck Squamous Cell Carcinoma
Dermaprazole Cream for Radiation Dermatitis in Head and Neck Cancer
Mindfulness-based Stress Reduction Effects on Depression, Anxiety and Internalized Stigma Compared With Treatment-As-Usual Among Head and Neck Cancer Patients
Nab-Paclitaxel and Cisplatin or Nab-paclitaxel as Induction Therapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (HNSCC)
Post-Operative Antibiotic Efficacy in Clean Contaminated Head and Neck Surgery: A Randomized Controlled Trial
Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer
Head and Neck Cancer in Children: A Retrospective Study
The Effectiveness of a Thyme and Honey Spray for Oral Toxicities
A Web-Based Multimedia Intervention for Head and Neck Cancer Patients
Effects of Expiratory Muscle Strength Training on Airway Protection and Swallowing in Chronic Dysphagia After Radiation Therapy
Fluorescence Imaging in Head and Neck Cancer
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck
Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer
Radiotherapy With Humidification in Head And Neck Cancer
Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer
PET With [18F]HX4 in Head and Neck Cancer